论文部分内容阅读
西立伐他汀钠，１９９７年４月１４日以Ｌｉｐｏｂａｙ在英国注册上市。最近以商品名Ｂａｙｃｏｌ在美国获准上市。它是新的ＨＭＧＣｏＡ还原酶抑制剂，用于治疗对限制饮食效果不明显的原发性高胆固醇血症（Ⅱａ型和Ⅱｂ型）。【药效学】〔１，２〕本品可显著降低总胆固...
Cerivastatin sodium, which was registered in the United Kingdom on Lipobay on April 14, 1997. Recently licensed under the trade name Baycol in the United States. It is a new HMG CoA reductase inhibitor for the treatment of primary hypercholesterolemia (type IIa and type IIb) that is not apparent in limiting diet. [Pharmacodynamics] [1,2] This product can significantly reduce the total cholesterol ...